Skip to main content
Advertisement
Live broadcast

Scientists have discovered a feature of immune cells in type I diabetes

JCI: T cells with signs of self-renewal found in lymph nodes of people with diabetes
0
Photo: IZVESTIA/Sergey Lantyukhov
Озвучить текст
Select important
On
Off

In the lymph nodes next to the pancreas of people with type 1 diabetes, scientists have found an increased content of T cells with signs of the ability to persist and give rise to other immune cells. The researchers suggest that such cells can support a prolonged attack on insulin-producing cells. It is too early to talk about what was found in the donated tissues and why it is too early to talk about a new treatment, in the "Izvestia" article.

Why did scientists study lymph nodes?

In type 1 diabetes, the immune system attacks the beta cells of the pancreas that produce insulin. CD8+ T lymphocytes, immune cells capable of destroying other cells of the body, are involved in this process. One of the questions for researchers is how this autoimmune attack can persist for a long time.

Many studies of immunity in diabetes rely on blood samples. But the cells found in the bloodstream do not necessarily behave the same way as the cells directly in the pancreas and its associated lymph nodes. It is difficult to obtain these tissues from a living person. Therefore, a University of Florida team led by Liana Peters and Todd Brusco examined samples provided by the nPOD organ donor network.

The lymph nodes that receive lymph from the pancreas are of particular interest. Studies in mice have previously shown that T cells can be stored there, capable of maintaining a supply of immune cells attacking the pancreas. The authors of the new work checked whether there are similar cell populations in human tissues.

Which cells were found

At the first stage, the researchers compared the lymph nodes of ten donors with type 1 diabetes and 12 donors without diabetes. Using methods that make it possible to distinguish immune cells by a set of characteristic features, they found an increased content of a certain group of CD8+ T cells in people with diabetes. These cells had the features of so-called stem-like memory T cells. The result was additionally tested on another group of donor samples.

The word "stem-like" here does not mean that researchers have found ordinary stem cells. We are talking about T-lymphocytes, which in their characteristics resemble cells that can persist for a long time and maintain an immune response. The scientists also studied which genes are active in individual cells, and found signs of inflammatory activity with less pronounced signs of their final "exhaustion." The analysis also indicated a possible role of the IL-15 signaling agent in maintaining these cellular states.

"I think this is what can support the autoimmune process as a chronic condition," said Todd Brusco, director of the University of Florida Diabetes Institute, commenting on the alleged role of such cells. This explanation remains a hypothesis about the mechanism of the disease, which has yet to be tested.

What the tissue comparison showed

To better understand the possible connection of lymph nodes with the focus of inflammation, the researchers separately studied paired samples of lymph nodes and pancreas from two donors with diabetes. They were able to detect some related groups of CD8+ T cells in both tissues. At the same time, the cells in the pancreas had more pronounced signs of a condition associated with an active immune response. Some of the T cells with the markers that scientists were interested in were located next to the pancreatic islets containing beta cells.

These observations are consistent with the assumption that a supply of less mature T cells may remain in the lymph nodes, and after entering the pancreas, some of them acquire the properties of cells involved in the attack. But there was little overlap between the cell lines in the two tissues. The analysis of the donor material shows the condition of the tissues at a certain point in time and does not allow tracing the movement of specific cells in the human body over the years.

The authors of a separate comment in the Journal of Clinical Investigation emphasize another limitation: the exact relationship of the detected stem-like cells with T-lymphocytes, which actually recognize and attack beta cells, has not yet been established. Therefore, lymph nodes can be considered as a possible place of maintenance of the autoimmune process, but the study does not prove that the found cell population itself is its source.

Can the discovery help the treatment

The researchers hope that a detailed description of the cells and their molecular features will help to find ways to more accurately influence the autoimmune process. In particular, the team is considering the possibility of studying antibodies to identified cellular targets. The scientific article also discusses the IL-15 signaling pathway as a direction for further testing.

However, this work did not test the new drug on patients and did not show that exposure to the detected cells could stop type 1 diabetes. For such a conclusion, it is first necessary to confirm the role of the cell population in the development of the disease, and then to verify the safety and effectiveness of a possible intervention.

The authors themselves note the small sample size and differences between donors. In addition, samples of pancreas without diabetes were not enough to fully compare the immune cells of this organ between the groups. The next step is to examine more tissues and find out which of the detected cells are directly related to the prolonged attack on beta cells.

Переведено сервисом «Яндекс Переводчик»

Live broadcast